NASAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Nasal Vaccines Market, By Vaccine Type (Live attenuated vaccines, Inactivated vaccines, Subunit, recombinant, and conjugate vaccines, and Others (such as DNA vaccines, viral vector vaccines, etc.)), By Application (Influenza, COVID-19, Other respiratory infections (such as RSV, pneumococcal, etc.) and Others (such as cholera, etc.)), By Distribution Channel (Public and Private ), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In: 26 Mar, 2025
Code: CMI5818
Pages: 160
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

N/A

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Nasal Vaccines Market, By Vaccine Type
  - Global Nasal Vaccines Market, By Application
  - Global Nasal Vaccines Market, By Distribution Channel
  - Global Nasal Vaccines Market, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rising burden of respiratory diseases or infections
  - Lack of healthcare infrastructure in developing economies
  - Increasing demand for safe and effective vaccines
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Nasal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Nasal Vaccines Market, By Vaccine Type, 2020-2032, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Live Attenuated Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Inactivated Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Subunit, Recombinant, and Conjugate Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Others (such as DNA Vaccines, Viral Vector Vaccines, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Global Nasal Vaccines Market, By Application, 2020-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Influenza
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- COVID-19
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Other Respiratory Infections (such as RSV, Pneumococcal, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Others (such as Cholera, Typhoid, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Global Nasal Vaccines Market, By Distribution Channel, 2025-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Public
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Private
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Global Nasal Vaccines Market, By Region, 2020-2032, (US$ Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- SINOVAC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bharat Biotech
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Altimmune
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- FluGen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vaxart
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Intravacc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gamma Vaccines Pty Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioNTech SE
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 35 market data tables and 31 figures on "Global Nasal Vaccines Market” – Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now